Electrophysiology device market seen reaching $12.06B by 2030

The global electrophysiology devices and equipment market is projected to grow from $7.9 billion in 2025 to $8.57 billion in 2026, then hit $12.06 billion by 2030, according to The Business Research Company. The report points to rising arrhythmia cases, AI-assisted systems and more outpatient cardiac procedures as major growth drivers.

Why it matters: - Electrophysiology devices are central to diagnosing and treating heart rhythm disorders, a growing slice of cardiovascular care. - The market's projected climb signals more demand for cardiac mapping, ablation and catheter-based procedures as hospitals and clinics upgrade their treatment tools. - Rising cardiovascular disease rates make specialized electrophysiology care more important for patients and health systems.

What happened: - The Business Research Company released an outlook on the global electrophysiology devices and equipment market. - The market is expected to rise from $7.9 billion in 2025 to $8.57 billion in 2026. - The report projects the market will reach $12.06 billion by 2030. - North America held the largest share of the market in 2025. - Western Europe ranked second among regions covered. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - Electrophysiology devices and equipment include medical tools used to monitor, analyze and manage the heart's electrical activity. - The category includes catheters, mapping systems and ablation technologies. - These devices support diagnosis of cardiac arrhythmias, minimally invasive procedures and broader cardiovascular treatment outcomes. - The market's recent growth has been driven by more arrhythmia cases, wider use of interventional cardiology, growth in electrophysiology laboratories, better access to advanced cardiac devices and higher awareness of heart rhythm disorders. - The report forecasts an 8.9% compound annual growth rate through 2030. - Future growth is tied to tailored cardiac treatments, greater use of AI-assisted electrophysiology systems, more outpatient cardiac procedures, more investment in cardiac care infrastructure and a stronger focus on treatment outcomes. - The report highlights cardiac mapping, minimally invasive ablation, 3D imaging and navigation, catheter-based techniques and more precise diagnostics as key trends. - A Minnesota Department of Health update in September 2024 said nearly 30% of adults in Minnesota reported high blood pressure in 2023, equal to about 1.4 million people. - The same update said hypertensive diseases caused or contributed to 14,225 deaths in 2022, nearly 28% of all deaths in the state.

Between the lines: - The report frames electrophysiology as part of a wider shift toward more targeted and less invasive cardiac care. - AI, imaging and navigation tools are moving from add-ons to core features in next-generation electrophysiology systems. - Regional leadership in North America suggests the market remains concentrated where advanced cardiac care infrastructure is already deepest.

What's next: - The market's next phase will likely center on outpatient growth, higher-precision diagnostics and wider use of minimally invasive procedures. - Investment in cardiac care infrastructure and digital tools could help push adoption through 2030. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - More information is available through the company's LinkedIn page.